medigraphic.com
SPANISH

Acta Médica Grupo Angeles

Órgano Oficial del Hospital Angeles Health System
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
    • Names and affiliations of the Editorial Board
  • Policies
  • About us
    • Data sharing policy
    • Stated aims and scope
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2026, Number 2

<< Back Next >>

Acta Med 2026; 24 (2)

Etiology of vertebral destruction syndrome in a Third Level Hospital in Mexico City

Ramos TJ, Mora RFG, Pérez FJA, Pérez JE, Domínguez GRC, Romero GED
Full text How to cite this article 10.35366/122612

DOI

DOI: 10.35366/122612
URL: https://dx.doi.org/10.35366/122612

Language: Spanish
References: 18
Page: 108-111
PDF size: 236.09 Kb.


Key words:

syndrome, destruction, etiology, infection, tumor.

ABSTRACT

Introduction: vertebral destruction syndrome encompasses pathologies that cause structural alterations in the vertebral body, producing deformity with neurological, mechanical, infectious, tumoral, and metabolic involvement. Objective: to identify the most frequent etiology of vertebral destruction syndrome in the population of the Ignacio Zaragoza “General Regional Hospital”. Material and methods:a cross-sectional, descriptive, retrospective, observational study was carried out during the period from January 2019 to December 2023, in patients of both genders, hospitalized with a confirmed diagnosis of vertebral destruction syndrome, with a complete clinical record. Results: a sample of 99 patients with a diagnosis of vertebral destruction syndrome was obtained, reporting tumor etiology in 36.3% followed by infectious etiology in 33.3%, and metabolic etiology in 30.3%; with a gender report of 85.5% female and 14.5% male, predominating in the age range of 65 to 70 years. Conclusion: vertebral destruction syndrome is more common in the female sex in the age range of 65 to 70 years, with tumor etiology being the most prevalent due to metastatic lesions that comprise nearly 97% of all spinal tumors, followed by infectious etiology due to vertebral osteomyelitis, and osteoporosis due to a crush fracture.


REFERENCES

  1. DeSanto J, Ross JS. Spine infection/inflammation. Radiol Clin NorthAm. 2011; 49 (1): 105-127.

  2. Tay BKB, Deckey J, Hu SS. Spinal infections. J Am Acad Orthop Surg.2002; 10 (3): 188-197.

  3. Rasouli MR, Mirkoohi M, Vaccaro AR, Yarandi KK, Rahimi-MovagharV. Spinal tuberculosis: diagnosis and management. Asian Spine J.2012; 6 (4): 294-308.

  4. De Luca S, Mondello E, Oviedo S, Tisser L, Eyheremendy EP, RicaC. Espondilodiscitis por Candida albicans. Revista Argentina deRadiología. 2008; (1): 23-25.

  5. Lado FL, Villamil CI, Rodríguez CI, Van den Eyden E. Espondilodiscitispor Candida albicans. Aportación de dos nuevos casos. An MedInterna. 2005; 22 (2): 76-78.

  6. Pertuiset E, Beaudreuil J, Lioté F, Horusitzky A, Kemiche F, Richette Pet al. Spinal tuberculosis in adults. A study of 103 cases in a developedcountry, 1980-1994. Medicine (Baltimore). 1999; 78 (5): 309-320.

  7. Gómez ELN, Larruz QJ. Infecciones de la columna vertebral en eladulto. Rev Mex Ortop Traum. 2000; 14 (4): 321-327.

  8. Mesfin A, Buchowski JM, Gokaslan ZL, Bird JE. Management ofmetastatic cervical spine tumors. J Am Acad Orthop Surg. 2015;23(1): 38-46.

  9. Switlyk MD, Kongsgaard U, Skjeldal S, Hald JK, Hole KH, Knutstad Ket al. Prognostic factors in patients with symptomatic spinal metastasesand normal neurological function. Clin Oncol (R Coll Radiol). 2015;27 (4): 213-221.

  10. Walker MP, Yaszemski MJ, Kim CW, Talac R, Currier BL. Axialmetastatic bone disease. Metastatic disease of the spine: evaluationand treatment. Clin Orthop Relat Res. 2003; (415 Suppl):S165-S175.

  11. Edelstyn GA, Palmer P, Grebell E. The radiologic demonstration ofosseous metastases. Exp Observ Clin Radiol. 1967; 18: 158-164.

  12. Lorente-Ramos R, Azpeitia-Armán J, Muñoz-Hernández A, García-Gómez JM, Díez-Martínez P, Grande-Bárez M. Dual-energy x-rayabsorptiometry in the diagnosis of osteoporosis: a practical guide.AJR Am J Roentgenol. 2011; 196 (4): 897-904.

  13. Holgado PS, Sallés LM, Olivé MA. Enfermedad ósea de Paget. MedClin (Barc). 2008; 131 (13): 509-512.

  14. Mylona E, Samarkos M, Kakalou E, Fanourgiakis P, Skoutelis A.Pyogenic vertebral osteomyelitis a systematic review of clinicalcharacteristics. Semin Arthritis Rheum. 2009; 39 (1): 10-17.

  15. Santo J: Tratamiento quirúrgico de las metástasis vertebrales,Actualidad en Traumatología, Tendencias. 2006, 1-4.

  16. Alpízar-Aguirre A, Elías-Escobedo A, Rosales-Olivares LM,Miramontes-Martínez V, Reyes-Sánchez A. Síndrome de destrucciónvertebral, sistemas de evaluación en su diagnóstico. Cir Cir. 2008;76 (3): 205-211.

  17. Reyes-Sánchez A, Obil C. Usefulness of computed tomography(CT)-guided biopsy for etiological diagnosis of vertebral destructionsyndrome. J Spine. 2016; 5 (2): 1000295.

  18. Jiménez-Ávila JM, Cahueque M, Cobar A, Bregni MC. Vertebral destructionsyndrome: from knowledge to practice. J Spine. 2015; 4: 251.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Acta Med. 2026;24